<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="of necessary drugs (antihistamine, corticosteroid, and adrenaline) and two available" exact="adrenaline" post="auto-injectors. In children with food allergies (FA), the avoidance"/>
 <result pre="of necessary drugs (antihistamine, corticosteroid, and adrenaline) and two available" exact="adrenaline" post="auto-injectors. The child/adolescent suffering from food allergies must consume"/>
 <result pre="prevalence of 0.07â€&quot;0.7% in children [33]. In the case of" exact="Azithromycin" post="hypersensitivity, an antibiotic of the same class (i.e., clarithromycin)"/>
 <result pre="low grade of cross-reactivity after ascertaining tolerance under medical surveillance." exact="Hydroxychloroquine" post="exposes some patients to the risk of rare but"/>
 <result pre="patients to the risk of rare but potentially fatal SCARs." exact="Azithromycin" post="and Hydroxychloroquine co-treatment can be safely performed after a"/>
 <result pre="the risk of rare but potentially fatal SCARs. Azithromycin and" exact="Hydroxychloroquine" post="co-treatment can be safely performed after a cardiological evaluation"/>
 <result pre="used to identify safe alternative heparin. In patients with assessed" exact="chlorhexidine" post="hypersensitivity, the use of this disinfectant is contraindicated during"/>
 <result pre="disinfectant is contraindicated during the COVID-19 pandemic. Low concentrations of" exact="chlorhexidine" post="should be used to prevent sensitization. Chlorhexidine is used"/>
 <result pre="Low concentrations of chlorhexidine should be used to prevent sensitization." exact="Chlorhexidine" post="is used as disinfectant and antiseptic, but it is"/>
 <result pre="dermatitis can be provoked by its frequent use [35]. Moreover," exact="chlorhexidine" post="can cause immediate systemic reactions such as anaphylaxis [36]."/>
 <result pre="immediate systemic reactions such as anaphylaxis [36]. Higher concentrations of" exact="chlorhexidine" post="irritate the skin and increase the risk of sensitization"/>
 <result pre="health workers during the COVID-19 pandemic, an increased incidence of" exact="Chlorhexidine" post="allergy could develop. The use of low concentrations of"/>
 <result pre="Chlorhexidine allergy could develop. The use of low concentrations of" exact="chlorhexidine" post="(0.5â€&quot;2% weight/volume) is suggested to prevent sensitization. Patients with"/>
 <result pre="unresponsive to 2nd generation H1-antihistamines and omalizumab, ongoing treatment with" exact="cyclosporine" post="A should not be stopped during the COVID-19 pandemic."/>
 <result pre="CSU. However, due to a higher incidence of adverse effects," exact="cyclosporine" post="A is not recommended as a standard treatment in"/>
 <result pre="adolescents with CSU unresponsive to 2nd generation H1-antihistamines and omalizumab," exact="cyclosporine" post="A is suggested as a therapeutic option [38]. Similar"/>
 <result pre="a therapeutic option [38]. Similar to patients undergoing immunosuppressive treatment," exact="cyclosporine" post="A should not be stopped during COVID-19 pandemic and"/>
 <result pre="generation H1-antihistamines and omalizumab, we suggest delaying the beginning of" exact="cyclosporine" post="A treatment consistently with health conditions. Ongoing treatment with"/>
 <result pre="timely evaluation should be carried out on time. Moreover, an" exact="adrenaline" post="auto-injector should be promptly prescribed, and venom immunotherapy (VIT)"/>
 <result pre="[44â€&quot;46]. Thus, the appropriate diagnostic workup, the prescription of an" exact="adrenaline" post="auto-injector, and VITâ€™s performance are critical services, and they"/>
 <result pre="by inhalation spray or powder, anti-leukotriene agents, biological drugs, intramuscular" exact="adrenaline" post="should be administered according to the individual therapeutic plan"/>
 <result pre="the food in question; emergency therapy, self-injectable intramuscular adrenaline, and" exact="salbutamol" post="spray, according to the individual therapeutic plan [82]. During"/>
 <result pre="del Giudice M, Peroni D, et al. focus on the" exact="cetirizine" post="use in clinical practice: a reappraisal 30 years later."/>
 <result pre="Med. 2020; (in press). 13.James L. Olds, Kabbani N. Is" exact="nicotine" post="exposure linked to cardiopulmonary vulnerability to COVID-19 in the"/>
 <result pre="infections: individual participant data meta-analysisHealth Technol Assess20192314410.3310/hta23020 17.VorilhonPArpajouBVaillant RousselHMerlinEPereiraBCabaillotAEfficacy of" exact="vitamin C" post="for the prevention and treatment of upper respiratory tract"/>
 <result pre="Am Acad Dermatol. 2020; (in press). 21.Magdaleno-TapialJMartÃ­nez-DomÃ©nechAValenzuela-OÃ±ateCFerrer-GuillÃ©nBEsteve-MartÃ­nezAZaragoza-NinetVAllergic contact dermatitis to" exact="chlorhexidine" post="in pediatric patientsPediatr Dermatol20193654054110.1111/pde.1380830838689 22.Stone TE, Kunaviktikul W, Omura"/>
 <result pre="Covid-19. N Enl J Med. 2020; (in press). 33.XuPSafety of" exact="azithromycin" post="in pediatrics: a systematic review protocolBMJ Paediatr Open201931e00046910.1136/bmjpo-2019-000469 34.Gonzalez-DelgadoPFernandezJHypersensitivity"/>
 <result pre="Dermatologists guidelines for the safe and effective prescribing of oral" exact="ciclosporin" post="in dermatology 2018Br J Dermatol20181801312133810.1111/bjd.17587 40.collab: British Association of"/>
</results>
